LEVALBUTEROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levalbuterol, and when can generic versions of Levalbuterol launch?
Levalbuterol is a drug marketed by Cipla, Impax Labs Inc, Luoxin Aurovitas, Mankind Pharma, Mylan Speciality Lp, Pharmobedient, Ritedose Corp, Sun Pharm, Teva Parenteral, and Teva Pharms Usa. and is included in eleven NDAs.
The generic ingredient in LEVALBUTEROL is levalbuterol hydrochloride. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the levalbuterol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levalbuterol
A generic version of LEVALBUTEROL was approved as levalbuterol hydrochloride by IMPAX LABS INC on April 9th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LEVALBUTEROL?
- What are the global sales for LEVALBUTEROL?
- What is Average Wholesale Price for LEVALBUTEROL?
Summary for LEVALBUTEROL
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Drug Prices: | Drug price information for LEVALBUTEROL |
| DailyMed Link: | LEVALBUTEROL at DailyMed |
US Patents and Regulatory Information for LEVALBUTEROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cipla | LEVALBUTEROL HYDROCHLORIDE | levalbuterol hydrochloride | SOLUTION;INHALATION | 078171-002 | Dec 13, 2013 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ritedose Corp | LEVALBUTEROL HYDROCHLORIDE | levalbuterol hydrochloride | SOLUTION;INHALATION | 203653-001 | Mar 22, 2016 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva Parenteral | LEVALBUTEROL HYDROCHLORIDE | levalbuterol hydrochloride | SOLUTION;INHALATION | 200875-001 | Sep 11, 2014 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Luoxin Aurovitas | LEVALBUTEROL HYDROCHLORIDE | levalbuterol hydrochloride | SOLUTION;INHALATION | 207628-001 | Jan 31, 2017 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Impax Labs Inc | LEVALBUTEROL HYDROCHLORIDE | levalbuterol hydrochloride | SOLUTION;INHALATION | 077756-003 | Apr 9, 2008 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
